In Tuesday’s Blitz Daily with Lance Ippolito, we take a look at continued earnings season flow in IT service management company Marqeta.
Marqeta is a payment processing and card issuing platform that acts as a bridge between traditional payment processors and more disruptive companies like Affirm, DoorDash and Square.
As an example of what Marqeta does, the company partnered with Square to introduce the Square Card for small business owners. With this card, owners can access their earnings immediately and without paying additional fees to do so, allowing them to reinvest in their business to keep it running.
And it seems the smart money is looking for Marqeta to continue to innovate in the fintech space!
With the stock currently trading around $7 per share, they’re looking for an upward move of more than 7% following the company’s earnings report.
If you don’t find Marqeta to be a game-changer, I have more order flow hitting the tape…
Disclaimer : The material in this document is for informational purposes based on our proprietary research. It is not an offering, specific recommendation, or a solicitation of an offer to buy or sell any securities mentioned or discussed herein.
Any performance results discussed herein represent past performance, are not a guarantee of future performance, and are not indicative of any specific investment.
Due to the timing of information presented, any investment performance reflected within this document may be adjusted after the publication and distribution of this material. There can be no assurance that the future performance of any specific investment, investment strategy, or product made reference to directly or indirectly in this communication will be profitable, be equal to any corresponding indicated historical performance levels or be suitable for your portfolio. Any investment results set forth in this document are not net of expenses and execution costs, nor do they account for other relevant trading or investment fees. Please visit wealthpress.com/terms for our full Terms and Conditions.
0 Response to "Bulls Buy the Blood Ahead of Marqeta Earnings"
Post a Comment